Submit
logo

WhiteOak Capital Pharma And Heathcare Fund Regular Plan Growth

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 06-02-2024
AUM:

₹ 926.55 Cr

Expense Ratio

2.76%

Benchmark

BSE Healthcare TRI

ISIN

INF03VN01878

Minimum Investment

500.0

Minimum Topup

500.0

Minimum SIP Amount

100

Fund Manager

Mr. Ramesh Mantri, Mr. Dheeresh Pathak, Mr. Piyush Baranwal, Mr. Ashish Agrawal, Ms. Trupti Agarwal

Fund Performance 1Y (%) 3Y (%) 5Y (%)
WhiteOak Capital Pharma And Heathcare Fund Regular Plan Growth 15.08 - -
Benchmark - - -
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
16.225
Last change
0.48 (2.9584%)
Fund Size (AUM)
₹ 926.55 Cr
Performance
19.16% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.

Fund Manager
Mr. Ramesh Mantri, Mr. Dheeresh Pathak, Mr. Piyush Baranwal, Mr. Ashish Agrawal, Ms. Trupti Agarwal
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- 8.36
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- 7.11
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- 6.26
Clearing Corporation of India Ltd 5.55
LAURUS LABS LIMITED EQ NEW FV RS. 2/- 3.91
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- 3.75
CIPLA LIMITED EQ NEW FV RS.2/- 3.68
Sai Life Sciences Limited 3.28
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- 2.88
ZYDUS LIFESCIENCES LIMITED EQ NEW FV RE. 1/- 2.81

Sector Allocation

Sector Holdings (%)
Healthcare 86.0
Chemicals 2.88
Capital Goods 1.84

Peer Comparison

Scheme Name 5Y (%)
WhiteOak Capital Pharma And Heathcare Fund Reg Plan Gr 0.0